A sector of the pharmaceutical market known as "high-margin specialty drugs" is presenting us with the best pharmaceutical stocks to buy now. According to experts at PricewaterhouseCoopers, consumer spending on high-margin specialty drugs hit $87.1 billion in 2012. In five years that number will quadruple to $401.7 billion. The Wall Street Journal reports that total U.S. prescription drug spending was just $325.7 billion in 2012. The post These Pharmaceutical Stocks Let You Tap into a $402 Billion Trend appeared first on Money Morning - We Make Investing Profitable .